A Single-Cell Atlas of Tumor-Infiltrating Immune Cells in Pancreatic Ductal Adenocarcinoma
Hao Wang(Capital Medical University), Ruibing Chen(Tianjin University of Science and Technology), Hongle Li(Shanghai Jiao Tong University), Lisha Qi(Tianjin Medical University Cancer Institute and Hospital), Zhibin Zhang(Chinese Academy of Sciences), Ning Zhang(Peking University), Lu Chen(Army Medical University), Jun Li(Sun Yat-sen University), Hua Guo(Shanxi Medical University), Na Jiang(Central South University), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital)
Cited by 11
Related Papers
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
|Molecules|2008|770
Merging paleobiology with conservation biology to guide the future of terrestrial ecosystems
|Science|2017|392
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300